Alliancebernstein L.P. Procept Bio Robotics Corp Transaction History
Alliancebernstein L.P.
- $275 Billion
- Q1 2024
A detailed history of Alliancebernstein L.P. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,985,817 shares of PRCT stock, worth $121 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,985,817
Previous 2,056,350
3.43%
Holding current value
$121 Million
Previous $86.2 Million
13.88%
% of portfolio
0.04%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding PRCT
# of Institutions
173Shares Held
38.1MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$326 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$259 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$201 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.94MShares$180 Million0.09% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.57MShares$96.1 Million0.46% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.72B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...